612 results on '"Barletta F"'
Search Results
2. PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy
3. Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series
4. Assessing epigenetic features associated with lymph node metastases in prostate cancer
5. Optimizing detection and prediction of prostate cancer after positive MRI and negative biopsies
6. Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy
7. The significant added value of concomitant systematic prostate biopsies in addition to targeted sampling in patients with previous negative biopsies. Implications for accurate staging predictions from a large multi-institutional series
8. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study
9. Prognostic significance of lymph node count in surgically treated patients with T2-4 stage non-metastatic adrenocortical carcinoma
10. Identifying the optimal definition of PSA response after metastasis directed therapy in men with oligo-recurrent prostate cancer detected at PSMA PET
11. Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials
12. The effect of treatment dose intensification on other-cause mortality in clear-cell metastatic renal cell carcinoma patients
13. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging
14. Effect of Metastasis Directed Therapy (MDT) in men with PSMA PET detected recurrent prostate cancer according to time from primary treatment. Do men with late recurrences really benefit from MDT? Results from a large, single institution series
15. The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series
16. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
17. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series
18. Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis
19. When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification
20. Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy
21. Adenocarcinoma of the bladder: Assessment of survival benefit associated with radical cystectomy and comparison with urothelial bladder cancer
22. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer
23. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series
24. Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study
25. Introducing the speech therapist in the Neonatology Unit: an innovative way to support breastfeeding in healthy newborns even during COVID-19 pandemic
26. Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series
27. Topographic description of the site of positive MPMRI and impact on the risk of positive surgical margins at robot-assisted nerve sparing radical prostatectomy. implications for accurate surgical approaches
28. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
29. 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study
30. Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? a prospective assessment using a standardized collection system
31. When is neoadjuvant androgen deprivation therapy beneficial for highly aggressive prostate cancer before radical prostatectomy? implications for multi-modal tailored approaches and trials design
32. Can low risk disease outside the index lesion be left untreated in men suitable for focal therapy? development of novel criteria to identify potential candidates for focal therapy among patients with intermediate risk prostate cancer and positive multi-parametric MRI
33. When can we de-intensify treatments in isup grade group 5 prostate cancer? long-term results of a single center, high volume series
34. Optimizing timing and indications for 68Ga-PSMA PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy
35. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series
36. The impact of frailty status on surgical outcomes after robot-assisted radical prostatectomy - a prospective assessment using a standardized collection system for perioperative outcomes
37. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
38. Increased awareness of surgical outcomes improves long-term functional outcomes after robot-assisted radical prostatectomy. A prospective assessment following implementation of prospective data collection
39. The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting
40. Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort
41. Assessing the role of frailty status on oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for localized prostate cancer
42. 99m-Technetium-PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing with radical prostatectomy and extended pelvic lymph node dissection
43. Comparative analyses of micro-ultrasound versus MRI-targeted biopsy for the diagnosis of clinically significant prostate cancer. Preliminary results from the prospective us-mirror trial
44. Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series
45. Histological variants of prostate cancer are under-reported in prostate biopsies assessed outside tertiary referral centers. a plea for biopsy review for optimal patient management
46. Delaying post-operative radiation therapy after radical prostatectomy is associated with increased functional outcomes: results from a large single, referral center series
47. When node-positive prostate cancer should be considered a systemic disease? assessing the prognostic role of preoperative 68Ga-PSMA PET/ CT results in patients with lymph node invasion at final pathology
48. Not all adverse pathology features are equal: identifying optimal candidates for adjuvant radiotherapy among patients with adverse pathology at radical prostatectomy
49. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
50. RISK OF ADVERSE RADICAL PROSTATECTOMY OUTCOMES IN PATIENTS DIAGNOSED WITH IUSP <= 2 PROSTATE CANCER ON MRI/TRUS FUSION BIOPSY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.